XORTX Therapeutics Inc. Common Shares share price logo

XORTX Therapeutics Inc. Common Shares

NASDAQ: XRTX

Small Cap

$2.09

-0.06

(-2.79%)

as on

XORTX Therapeutics Inc. Common Shares Stock Performance

as on June 19, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $2.00
    $2.15
    downward going graph

    4.31%

    Downside

    2.87%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.73
    $7.05
    downward going graph

    17.46%

    Downside

    237.32%

    Upside

    downward going graph

XORTX Therapeutics Inc. Common Shares share price movements today

Previous Close
$2.15
Open
$2.15
Volume
456.2K
Day's Low - High
$2.00 - $2.15
52 Week Low - High
$1.73 - $7.05

XORTX Therapeutics Inc. Common Shares Historical Returns

1 Month Return
-9.91 %
3 Month Return
+ 1.95 %
1 Year Return
-51.4 %
3 Year Return
-92.9 %
5 Year Return
0 %

XORTX Therapeutics Inc. Common Shares Stock Fundamentals & Key Indicators

Check XORTX Therapeutics Inc. Common Shares market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.5M

EPS (TTM)

-0.482

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.97%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-2.4M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-137.44%

XORTX Therapeutics Inc. Common Shares vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of XORTX Therapeutics Inc. Common Shares with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
XORTX Therapeutics Inc. Common Shares image
XORTX Therapeutics Inc. Common Shares
BUY$3.5MNANA0.00%NA
Alnylam Pharmaceuticals Inc. image
Alnylam Pharmaceuticals Inc.
BUY$37.7B57.21%71.2112.55%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$116.5B140.42%27.2235.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$63.7B13.39%14.8529.65%0.58%

Stock Returns calculator for XORTX Therapeutics Inc. Common Shares Stock including INR - Dollar returns

The XORTX Therapeutics Inc. Common Shares stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

XORTX Therapeutics Inc. Common Shares investment value today

Current value as on today

₹52,944

Returns

-₹47,056

(-47.06%)

Returns from XORTX Therapeutics Inc. Common Shares Stock

-₹51,395 (-51.4%)

Dollar Impact

₹4,340 (+4.34%)

Analyst Recommendation on XORTX Therapeutics Inc. Common Shares Stock

Based on 5 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 5 analysts, 80% of analysts recommend a 'BUY' rating for XORTX Therapeutics Inc. Common Shares. Average target price of $14.04

XORTX Therapeutics Inc. Common Shares Share Price Target

Get share price movements and forecasts by analysts on XORTX Therapeutics Inc. Common Shares.

What analysts predicted

85.11%UPSIDE

Target Price

$14.04

Current Price

$2.09

Analyzed by

5 Analysts

Target

$14.04

XORTX Therapeutics Inc. Common Shares target price $14.04, a slight upside of 85.11% compared to current price of $2.09. According to 5 analysts rating.

Indian Investors' Interest in XORTX Therapeutics Inc. Common Shares Stock

Search interest for XORTX Therapeutics Inc. Common Shares Stock has decreased by -76% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-76% versus previous 30 day period

XORTX Therapeutics Inc. Common Shares Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
0
-1
-3
0
0
0
0
0
0
0
EBITDA
0
-1
-1
0
0
0
0
0
0
0
Interest Expense
-
0
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
2
-3
0
0
0
0
0
0
0
0
Income Tax Expense
-3
1
0
-
-
-
-
-
-
-
Net Income
2
-3
0
0
0
0
0
0
0
0
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

XORTX Therapeutics Inc. Common Shares Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
-
0
0
0
0
0
0
0
0
Operating Income
0
-1
0
-1
-2
-12
-6
-3
-3
EBITDA
0
-1
0
-1
-2
-9
-6
-3
-3
Interest Expense
0
0
0
0
0
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
0
-3
0
-1
-1
-9
-2
-3
-2
Income Tax Expense
0
0
0
0
0
-
-
-
-
Net Income
0
-2
0
-1
-1
-5
-2
-3
-2
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

XORTX Therapeutics Inc. Common Shares Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-3
0
0
0
0
0
0
0
0
Operating Cash Flow
-1
0
0
0
0
0
0
0
0
Investing Cash Flow
0
0
0
0
0
0
0
0
0
Financing Cash Flow
1
0
0
1
0
0
0
0
0
Change in Cash
0
0
0
0
0
0
0
0
0

XORTX Therapeutics Inc. Common Shares Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
-3
0
-1
-1
-7
-2
-3
-2
Operating Cash Flow
0
0
0
0
-4
-8
-6
-3
-2
Investing Cash Flow
0
0
0
0
0
0
0
0
0
Financing Cash Flow
0
1
0
0
19
3
0
2
1
Change in Cash
0
0
0
0
14
-4
-6
0
-1

Global Institutional Holdings in XORTX Therapeutics Inc. Common Shares

Funds
Holdings
TWO SIGMA SECURITIES, LLC
0%
Armistice Capital, LLC
0%
Advisor Group Holdings, Inc.
0%
NATIONAL BANK OF CANADA /FI/
0%
Citadel Advisors Llc
0%
See all

XORTX Therapeutics Inc. Common Shares News & Key Events

  • img

    Today's Timeline - 29 October

    Wed, 04:31 PM

    -

    XORTX Therapeutics closes US$1.1 million registered direct offering for working capital and corporate purposes.

Insights on XORTX Therapeutics Inc. Common Shares

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 19.7% return, outperforming this stock by 71.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, XORTX Therapeutics Inc. Common Shares has experienced a drawdown of -93.3%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 71.4%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, XRTX stock has moved down by -93.3%

About XORTX Therapeutics Inc. Common Shares

XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat hyperuricemia related diseases in Canada. It develops XRx-026, which is in Phase III for the treatment of gout; XRx-008, which is in Phase II for the treatment of autosomal dominant polycystic kidney disease; XRx-101, which is in Phase II for the treatment of acute kidney injury associated with respiratory virus infection, including sepsis and coronavirus; and XRX-225, which is in preclinical stage for the treatment of type 2 diabetic nephropathy, as well as VB4-P5, a program for the treatment and prevention of fibrosis in the kidney. The company is based in Calgary, Canada.
OrganisationXORTX Therapeutics Inc. Common Shares
Headquarters3710 - 33rd Street NW, Calgary, AB, Canada, T2L 2M1
IndustryBiotechnology
CEODr. Michael Scott Bumby D.V.M., M.B.A.
E-voting on sharesClick here to vote

Key Management of XORTX Therapeutics Inc. Common Shares

Name

Title

Nick Rigopulos

Director of Communications

Dr. David Sans M.B.A., Ph.D.

Director of Corporate Development

Dr. David MacDonald Ph.D.

Consultant of Clinical Operations

Ms. Charlotte May

Corporate Secretary

Dr. Michael Scott Bumby D.V.M., M.B.A.

Chief Financial Officer

Dr. Stephen Haworth M.D., MRCP

Chief Medical Officer

Dr. Stacy Evans M.B.A., M.D.

Chief Business Officer

FAQs

What is XORTX Therapeutics Inc. Common Shares share price today?

XORTX Therapeutics Inc. Common Shares share price today is $2.09 as on at the close of the market. XORTX Therapeutics Inc. Common Shares share today touched a day high of $2.15 and a low of $2.

What is the 52 week high and 52 week low for XORTX Therapeutics Inc. Common Shares share?

XORTX Therapeutics Inc. Common Shares share touched a 52 week high of $7.05 on and a 52 week low of $1.73 on . XORTX Therapeutics Inc. Common Shares stock price today i.e. is closed at $2.09,which is 70.35% down from its 52 week high and 21.16% up from its 52 week low.

What is XORTX Therapeutics Inc. Common Shares's market capitalisation today?

XORTX Therapeutics Inc. Common Shares market capitalisation is $0.00T as on .

How to invest in XORTX Therapeutics Inc. Common Shares Stock (XRTX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for XORTX Therapeutics Inc. Common Shares on INDmoney app. Click on Buy button. You can invest as low as $1.5 in XORTX Therapeutics Inc. Common Shares Shares that will get you 0.7177 shares as per XORTX Therapeutics Inc. Common Shares share price of $2.09 per share as on June 19, 2026 at 8:46 am IST.

What is the minimum amount required to buy XORTX Therapeutics Inc. Common Shares Stock (XRTX) from India?

Indian investors can start investing in XORTX Therapeutics Inc. Common Shares (XRTX) shares with as little as ₹94.31 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.10 in XORTX Therapeutics Inc. Common Shares stock (as per the Rupee-Dollar exchange rate as on ). Based on XORTX Therapeutics Inc. Common Shares share’s latest price of $2.09 as on June 19, 2026 at 8:46 am IST, you will get 4.7847 shares of XORTX Therapeutics Inc. Common Shares. Learn more about fractional shares .